http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15198137
Outgoing Links
Predicate
Object
contentType
Journal Article|Review
endingPage
139
issn
0920-1211
issueIdentifier
2
pageRange
107-139
publicationName
Epilepsy Research
startingPage
107
bibliographicCitation
Perucca E, Beghi E, Dulac O, Shorvon S, Tomson T. Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Res. 2000 Sep;41(2):107–39. doi: 10.1016/s0920-1211(00)00124-8. PMID: 10940614.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_980f12f3c9c987a1be8d6e28e4f18ee9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3d7a8c272a89585a5168505489182f5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_450470403a560ceec3938a243dcd6a80
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_974164ff1fce4783869812c00a1a96ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae13f3e6f9b48a520541a78795a5bed1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2542-0469
date
200008
identifier
https://pubmed.ncbi.nlm.nih.gov/10940614
https://doi.org/10.1016/s0920-1211%2800%2900124-8
isPartOf
https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title
Assessing risk to benefit ratio in antiepileptic drug therapy
discusses
http://id.nlm.nih.gov/mesh/M0001382
hasPrimarySubjectTerm
http://id.nlm.nih.gov/mesh/D004827Q000517
http://id.nlm.nih.gov/mesh/D000927Q000009
http://id.nlm.nih.gov/mesh/D004827Q000188
http://id.nlm.nih.gov/mesh/D000927Q000191
hasSubjectTerm
http://id.nlm.nih.gov/mesh/D004827Q000150
http://id.nlm.nih.gov/mesh/D003362
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D000927Q000627
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11492
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3331
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7095
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7618
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617
Total number of triples:
40
.